Evaluation of the Impact of Ambulatory Epidural on Maternal Satisfaction During Delivery and Postpartum
NCT ID: NCT06550570
Last Updated: 2025-07-04
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
126 participants
OBSERVATIONAL
2024-07-23
2025-08-23
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Assessment of the Expectations and Fears of Pregnant Patients Monitored at the CMCO Regarding Ambulatory Epidural Anesthesia
NCT07345962
Evaluation of the Impact of an Outpatient Obstetric Epidurals During Labor
NCT02507739
Postpartum Quality of Recovery & Maternal Satisfaction After C/S
NCT05077891
Effect of Epidural Analgesia on Regional Lung Ventilation in Parturient Women as Assessed by Thoracic Impedance
NCT06195774
Management of Obstetrical Pain: " 7 Days Survey of Obstetric Analgesia/Anesthesia in France"
NCT02853890
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Practice changes are planned in concerned departments, in particular regarding usual patient care. This observational study aims to quantify the impact of practice changes on patient experience using a Childbirth Assessment Questionnaire (QEVA). During the "before" period, patients will receive a conventional epidural while the others, during the "after" period, will receive an ambulatory epidural. The women involved into this study must fill the QEVA form 2 days after giving birth (at the maternity) then 4 weeks after giving birth in order to get a feedback related to postpartum feelings (phone call).
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Conventional epidural anesthesia (=before revision of the usual practice of the maternity ward)
A local anesthetic and an opioid are administered into the epidural space, as per department protocol (usual practice).
QEVA questionnaire
QEVA questionnaire administered at 2 days pospartum (in hospital) and 4 weeks postpartum (phone call). (specific for the study)
Ambulatory epidural anesthesia (=after revision of the usual practice of the maternity ward)
Low doses of local anesthetic and an opioid are administered into the epidural space to allow the patient to walk around while being monitored, as per department revised protocol (usual practice)
QEVA questionnaire
QEVA questionnaire administered at 2 days pospartum (in hospital) and 4 weeks postpartum (phone call). (specific for the study)
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
QEVA questionnaire
QEVA questionnaire administered at 2 days pospartum (in hospital) and 4 weeks postpartum (phone call). (specific for the study)
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* with Physiological pregnancy (fetus cephalic position, normal fetal heart rate, spontaneous work between 37 and 41 SA)
* Having benefited from epidural, usual or ambulatory depending on the study period
* who speeks and understand French
* who signed a free and informed consent form
Exclusion Criteria
* Twin pregnancies
* Scarred uterus
* Fetus in non cephalic position
* Imminent delivery
* Women under protective supervision (guardianship, curatorship)
* Women bereaved of a spouse or child during pregnancy
* Hospitalization of child in neonatology after delivery
* Women hospitalized in critical care units after childbirth
18 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Centre Hospitalier Régional Metz-Thionville
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Lisa LEON, MD
Role: PRINCIPAL_INVESTIGATOR
CHR Metz Thionville Hopital Femme Mère Enfant
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CHR Metz Thionville Hopital Femme Mère Enfant
Metz, , France
CHR Metz-Thionville Hopital Mère Enfant
Thionville, , France
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2024-02Obs-CHRMT
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.